Comparison of Dual-Task Timed Up and Go Test (Cognitive) and 3-m Backwards Walk Test

NCT05211349 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-01-27

No results posted yet for this study

Summary

Two balance assessment tools that have been used recently have attracted considerable attention: the Dual-Task Timed Up and Go Test (cognitive) (DTUG) and the 3-m Backward Walk Test (3MBWT). The aim of this study is to compare the psychometric properties of two clinically proven balance assessment tools.

Conditions

Interventions

OTHER

Dual-Task Timed Up and Go Test (cognitive)

It evaluates balance with a simultaneous cognitive and motor task. The cognitive task of the test is serial triple subtraction while the TUG test is a motor task. Balance performance will be recorded in seconds.

OTHER

3-m Backward Walk Test

It is used to assess fall risk and balance. It is calculated in how many seconds an individual can walk backward a marked distance of 3 meters.

OTHER

Modified Four Square Step Test

It is a performance test that evaluates dynamic balance in stroke individuals with the ability to avoid obstacles and take steps in all directions. Balance performance is recorded in seconds.

OTHER

Timed Up and Go Test

It is used to assess balance and functional mobility. The participant is asked to get up from the chair she/he is sitting in, walk the marked distance of 3 meters and return to her/his seat again. The elapsed time is recorded in seconds.

OTHER

Berg Balance Test

It consists of 14 items and evaluates dynamic balance and functional mobility in stroke. The maximum score is 56. Higher scores indicate better balance.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • EMEL TAŞVURAN HORATA, PhD · AFSU

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-02
Primary Completion
2023-01-02
Completion
2024-01-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211349 on ClinicalTrials.gov